These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 2804692)
21. Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study. Szpak GM; Lechowicz W; Lewandowska E; Bertrand E; Wierzba-Bobrowicz T; Gwiazda E; Schmidt-Sidor B; Dymecki J Folia Neuropathol; 2001; 39(3):181-92. PubMed ID: 11770129 [TBL] [Abstract][Full Text] [Related]
22. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins). Bramblett GT; Trojanowski JQ; Lee VM Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956 [TBL] [Abstract][Full Text] [Related]
23. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex. van de Nes JA; Nafe R; Schlote W Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153 [TBL] [Abstract][Full Text] [Related]
24. ATP-induced loss of Alz-50 immunoreactivity with the A68 proteins from Alzheimer brain is mediated by ubiquitin. Vincent IJ; Davies P Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4840-4. PubMed ID: 2162059 [TBL] [Abstract][Full Text] [Related]
26. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Dickson DW; Ruan D; Crystal H; Mark MH; Davies P; Kress Y; Yen SH Neurology; 1991 Sep; 41(9):1402-9. PubMed ID: 1653914 [TBL] [Abstract][Full Text] [Related]
27. Pre- and post-critical period induced reduction of Cat-301 immunoreactivity in the lateral geniculate nucleus and visual cortex of cats Y-blocked as adults or made strabismic as kittens. Yin ZQ; Crewther SG; Wang C; Crewther DP Mol Vis; 2006 Aug; 12():858-66. PubMed ID: 16917486 [TBL] [Abstract][Full Text] [Related]
28. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments. Papasozomenos SC Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388 [TBL] [Abstract][Full Text] [Related]
29. Cytochrome oxidase in Alzheimer's disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems. Wong-Riley M; Antuono P; Ho KC; Egan R; Hevner R; Liebl W; Huang Z; Rachel R; Jones J Vision Res; 1997 Dec; 37(24):3593-608. PubMed ID: 9425533 [TBL] [Abstract][Full Text] [Related]
30. Early cytoskeletal changes as shown by Alz-50 are not accompanied by decreased neuronal activity. Salehi A; Van de Nes JA; Hofman MA; Gonatas NK; Swaab DF Brain Res; 1995 Apr; 678(1-2):28-39. PubMed ID: 7620896 [TBL] [Abstract][Full Text] [Related]
31. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients. van de Nes JA; Konermann S; Nafe R; Swaab DF Acta Neuropathol; 2006 Feb; 111(2):126-38. PubMed ID: 16456666 [TBL] [Abstract][Full Text] [Related]
32. Alz-50 immunoreactivity in the thalamic reticular nucleus in Alzheimer's disease. Tourtellotte WG; Van Hoesen GW; Hyman BT; Tikoo RK; Damasio AR Brain Res; 1990 May; 515(1-2):227-34. PubMed ID: 2357561 [TBL] [Abstract][Full Text] [Related]
33. The hypothalamic lateral tuberal nucleus in Alzheimer's disease. Kremer B; Swaab D; Bots G; Fisser B; Ravid R; Roos R Ann Neurol; 1991 Mar; 29(3):279-84. PubMed ID: 1710433 [TBL] [Abstract][Full Text] [Related]
34. Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain. Stephenson DT; Lemere CA; Selkoe DJ; Clemens JA Neurobiol Dis; 1996 Feb; 3(1):51-63. PubMed ID: 9173912 [TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. Hof PR; Cox K; Morrison JH J Comp Neurol; 1990 Nov; 301(1):44-54. PubMed ID: 2127598 [TBL] [Abstract][Full Text] [Related]
36. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease. Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182 [TBL] [Abstract][Full Text] [Related]
37. Elevation of cystatin C in susceptible neurons in Alzheimer's disease. Deng A; Irizarry MC; Nitsch RM; Growdon JH; Rebeck GW Am J Pathol; 2001 Sep; 159(3):1061-8. PubMed ID: 11549598 [TBL] [Abstract][Full Text] [Related]
38. Alzheimer-related neuronal protein A68: specificity and distribution. Wolozin B; Davies P Ann Neurol; 1987 Oct; 22(4):521-6. PubMed ID: 3435070 [TBL] [Abstract][Full Text] [Related]
39. Hierarchical Distribution of the Tau Cytoskeletal Pathology in the Thalamus of Alzheimer's Disease Patients. Rüb U; Stratmann K; Heinsen H; Del Turco D; Ghebremedhin E; Seidel K; den Dunnen W; Korf HW J Alzheimers Dis; 2016; 49(4):905-15. PubMed ID: 26519431 [TBL] [Abstract][Full Text] [Related]